The US FDA has cleared Tandem Diabetes Care’s Control-IQ+ technology for use in individuals aged 18 and above with type 2 ...

GE HealthCare has delivered the initial subject doses of Flyrcado (flurpiridaz F 18) injection, for coronary artery disease ...

Danish perfusion imaging specialist Cercare Medical has completed a €7.4m ($7.7m) funding round to expand operations into new ...

Fresenius Medical Care’s transformation plan has become evident in a 2024 earnings release as it continues to streamline its ...

UK-based OrganOx has received $142m in primary and secondary equity financing to propel the growth of its metra platform ...